PATENT CLAIM ANALYSIS

Application Number: 15876367
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
Methods and compositions of the invention relate to the enhancement of specific immunotherapies in cancer treatment. In particular, aspects of the invention relate to novel approaches to boost immune function using a complex carbohydrate pharmaceutical compound alone or in combination with other targeted immunotherapy to increase the efficacy of immunotherapy of cancer.

Claim (Index 15):
The method of  claim 14 , wherein the step of administering results in at least one of the following:\n at least 10% increase in the activation of CD8+ T-cells, CD4+ T-cells, or CD8+ T-cells and CD4+ T-cells, at least 10% increase of tumor-antigen specific CD8+ or CD4+ T-cells; at least 10% decrease in tumor size, at least 10% decrease in size of metastases, at least a 10% decrease in number of metastases, a reduction of total tumor burden, when compared to a control subject treated with the therapeutically effective amount of the immune modulatory agent alone.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.41026
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14029505', '13999389', '15087119', '15478599', '13998197']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8172850429391388
- 35 USC 102 Novelty (BERT): 0.713799373697612
- Combined Prediction Score: 0.8069364760149862
- Mean Citation Score: 550.234246
- Max Citation Score: 987.4825
- Similarity Product: 734.5344949355721

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test